Latest Feature

Gov. Deval Patrick's life sciences legacy

MassDevice.com looks at the life sciences legacy of former Massachusetts Gov. Deval Patrick.

Weight loss: ReShape Medical's Duo balloon system looks to curb obesity

A Q&A with ReShape Medical CEO Richard Thompson on the company's cash pay procedure and how it can make a dent in obese patients.

DeviceTalks podcast: Masimo CEO Kiani

An interview with medtech entrepreneur Joe Kiani, CEO of Masimo Corp. and the founder of the Patient Safety Movement Foundation, recorded at DeviceTalks West Nov. 19, 2014.

HeartFlow wins FDA OK for non-invasive FFR system

The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.

DeviceTalks podcast: B. Braun Medical CEO Caroll Neubauer on device tax, Obamaca

Caroll Neubauer, the CEO of B. Braun Medical, sits down for a wide-ranging interview on the hottest topics facing the medical device industry.

Latest Jobs

Knowledge Library

As many as 20 million young American women may be silently suffering from a debilitating disorder that few have ever heard of and even fewer admit to. That
Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

MassDevice.com +3 | The top 3 medtech stories for February 27, 2015

February 27, 2015 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Joint FDA panel recommends OK for Avedro's eye treatment

February 27, 2015 by Mark Hollmer

A joint meeting of 2 FDA advisory panels backs the use of Avedro's cross-linking technology to treat 2 eye conditions.

Joint FDA panel recommends OK for Avedro's eye treatment

Avedro said a joint meeting of 2 FDA advisory panels
considering its corneal cross-linking technology to treat 2 eye conditions this week voted to recommend approval.

Fines remain rare even as health data breaches multiply

February 27, 2015 by MassDevice

Federal health watchdogs say they are cracking down on organizations that don’t protect the privacy and security of patient records, but data suggests otherwise.

Fines remain rare even as health data breaches multiply
(David Sleight/ProPublica)

by Charles Ornstein, ProPublica

This story was co-published with NPR's Shots blog.

UnitedHealth tightens hysterectomy coverage

February 27, 2015 by MassDevice

UnitedHealth Group, the largest health insurer in the U.S., tightens its controls on hysterectomies performed using laparoscopic power morcellators.

UnitedHealth places tighter controls on hysterectomies

Report: India mulls boosting medtech import tariff

February 27, 2015 by Brad Perriello

India is reportedly considering raising its import tariff on medical devices by 5%.

Report: India mulls boosting medtech import tariff

The government of India is reportedly considering a 5% hike to the basic customs duty on imported medical devices, which make up 80% of its medtech market.

Medical device imports into India are hit with a tariff ranging from 5% to 10%, according to the Economic Times.

St. Jude Medical settles Riata, shareholder suits for $64m

February 27, 2015 by Brad Perriello

St. Jude Medical agrees to settle product liability lawsuits filed over its recalled Riata defibrillator leads and a class-action shareholder's suit accusing it of inflating results for its 2009 3rd quarter.

St. Jude Medical settles Riata, shareholder lawsuits for $64m

Royal Oak claims 'repless' generic sales model saves $100k a year

February 27, 2015 by Brad Perriello

Royal Oak Medical Devices touts its 'repless' generic sales model, saying it can save its hospital customers more than $100,000 a year on their orthopedic implant spends.

Royal Oak claims 'repless' sales model saves $100k a year

Royal Oak Medical Devices says it can save its hospital customers more than $100,000 a year on their orthopedic implant spends, using its so-called 'repless' generic sales model.

Nikon pushes into medtech with $400 mln Optos acquisition

February 27, 2015 by MassDevice

Nikon, best known for its cameras, moves into medtech with Optos buy

Optos

(Reuters) - Nikon, the 98-year-old Japanese company best known for its cameras, has agreed to buy British retinal imaging firm Optos for 259.3 million pounds ($400 million) as it moves into the medical sector.

Nikon has previously said it intended to enter the medical sector to leverage its optical technologies and the Japanese group sees buying Optos as an important step in that long-term growth plan.

Kazuo Ushida, president of Nikon, said the company would expand the medical business further in the future.